Pantoprazole Eg

Pantoprazole, the active ingredient in Pantoprazole Eg, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pantoprazole Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare neuroendocrine tumor. - NSA‑induced ulcer prophylaxis: lowers the risk of ulcer development in patients requiring long‑term non‑steroidal anti‑inflammatory therapy.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Abdominal pain or discomfort. - Nausea or vomiting. - Flatulence: increased gas production. - Constipation: occasional bowel habit changes.

Serious or Rare Side Effects: - Severe hypersensitivity reactions: rash, angioedema, or anaphylaxis. - Clostridioides difficile‑associated colitis: persistent watery diarrhea. - Acute interstitial nephritis: renal impairment signs. - Low magnesium levels (hypomagnesemia): muscle cramps or arrhythmia. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevations: hepatitis‑like picture.

Before initiating therapy, consider the following precautions: - Assess renal function: dose adjustment may be required in severe impairment. - Review hepatic status: monitor for accumulation in severe liver disease. - Evaluate need for long‑term use: prolonged therapy is linked to bone density loss. - Monitor electrolytes: especially magnesium during extended treatment. - Avoid abrupt discontinuation: may cause rebound acid hypersecretion. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Pantoprazole can affect the pharmacokinetics of several medicines. Interaction risk varies by the drug's metabolic pathway.

Major Interactions (Avoid): - Antifungal agents such as ketoconazole or itraconazole: reduced absorption and efficacy. - HIV protease inhibitors (e.g., atazanavir, nelfinavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect due to CYP2C19 inhibition.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR; monitor coagulation parameters. - Methotrexate (high dose): possible reduced clearance; check serum levels. - Digoxin: slight increase in serum concentration; observe for toxicity signs.